These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 17502840)

  • 41. Hormone therapy in the WHI era.
    Burger HG
    Aust N Z J Obstet Gynaecol; 2006 Apr; 46(2):84-91. PubMed ID: 16638027
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Simulation of the Syst-Eur randomized control trial using a primary care electronic medical record was feasible.
    Tannen RL; Weiner MG; Marcus SM
    J Clin Epidemiol; 2006 Mar; 59(3):254-64. PubMed ID: 16488356
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hormone therapy for the management of menopausal symptoms: pharmacotherapy update.
    Woodis CB
    J Pharm Pract; 2010 Dec; 23(6):540-7. PubMed ID: 21507860
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Menopausal hormone treatment cardiovascular disease: another look at an unresolved conundrum.
    Harman SM
    Fertil Steril; 2014 Apr; 101(4):887-97. PubMed ID: 24680648
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Is there a place for postmenopausal hormone therapy use in women with lupus?
    Gompel A; Piette JC
    Panminerva Med; 2008 Sep; 50(3):247-54. PubMed ID: 18927529
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Estrogen with and without progestin: benefits and risks of short-term use.
    LaCroix AZ
    Am J Med; 2005 Dec; 118 Suppl 12B():79-87. PubMed ID: 16414331
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Postmenopausal hormone therapy and the risk of cardiovascular disease.
    Bittner V
    Expert Opin Pharmacother; 2009 Sep; 10(13):2041-53. PubMed ID: 19563274
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Trends in hormone therapy use before and after publication of the Women's Health Initiative trial: 10 years of follow-up.
    Barbaglia G; Macià F; Comas M; Sala M; del Mar Vernet M; Casamitjana M; Castells X
    Menopause; 2009; 16(5):1061-4. PubMed ID: 19369903
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Invited commentary: hormone therapy and risk of coronary heart disease why renew the focus on the early years of menopause?
    Manson JE; Bassuk SS
    Am J Epidemiol; 2007 Sep; 166(5):511-7. PubMed ID: 17646204
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hormone replacement therapy and cardioprotection: a new dawn? A statement of the Study Group on Cardiovascular Disease in Women of the Italian Society of Cardiology on hormone replacement therapy in postmenopausal women.
    Rosano GM; Maffei S; Andreassi MG; Vitale C; Vassalle C; Gambacciani M; Stramba-Badiale M; Mercuro G
    J Cardiovasc Med (Hagerstown); 2009 Jan; 10(1):85-92. PubMed ID: 19145119
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Primary prevention of coronary heart disease in women.
    Rees M; Stevenson J;
    Menopause Int; 2008 Mar; 14(1):40-5. PubMed ID: 18380961
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Hormone replacement therapy: thoroughness in method and interpretation of results. Regarding the Women's Health Initiative--WHI].
    Burnand B; Cornuz J; Wirthner D; Lamy O
    Rev Med Suisse Romande; 2003 May; 123(5):277-81. PubMed ID: 15095709
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hormone use and patient concerns after the findings of the Women's Health Initiative.
    Rolnick SJ; Kopher RA; DeFor TA; Kelley ME
    Menopause; 2005; 12(4):399-404. PubMed ID: 16037754
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Osteoporosis management in a Medicaid population after the Women's Health Initiative study.
    Lee E; Wutoh AK; Xue Z; Hillman JJ; Zuckerman IH
    J Womens Health (Larchmt); 2006 Mar; 15(2):155-61. PubMed ID: 16536679
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Recent reversal of trends in hormone therapy use in a European population.
    Morabia A; Costanza MC
    Menopause; 2006; 13(1):111-5. PubMed ID: 16607106
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of the Women's Health Initiative study publication on hormone replacement therapy use among women who have undergone BRCA1/2 testing.
    Dorval M; Vallée MH; Plante M; Chiquette J; Gaudet M; Simard J
    Cancer Epidemiol Biomarkers Prev; 2007 Jan; 16(1):157-60. PubMed ID: 17220345
    [TBL] [Abstract][Full Text] [Related]  

  • 57. WHI and aftermath: looking beyond the figures.
    Pines A
    Maturitas; 2005 May; 51(1):48-50. PubMed ID: 15883109
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Estrogens, lipids, and heart disease.
    Barrett-Connor E; Miller V
    Clin Geriatr Med; 1993 Feb; 9(1):57-67. PubMed ID: 8443740
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Surgical menopause, estrogen, and cognitive function in women: what do the findings tell us?
    Sherwin BB
    Ann N Y Acad Sci; 2005 Jun; 1052():3-10. PubMed ID: 16024746
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Use of hormone replacement therapy in the Hong Kong public health sector after the Women's Health Initiative trial.
    Leung KY; Ling M; Tang GW
    Maturitas; 2005; 52(3-4):277-85. PubMed ID: 15950409
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.